ESR1 and breast carcinoma: When examined according to breast cancer sub-type, worse RFS of high expressers was observed in ER (Estrogen Receptor) positive cancers (Figure 8B and Figure 9B) but not in ER negative cases (Figure 8C and Figure 9C).